Key facts
- Shenzhen Shanhai Innovation Technology’s last known valuation is $77.0M (Mar 2021).
- It has raised $45.6M; the latest was Later Stage VC ($13.8M) in Apr 2025.
- Notable investors include Cowin Capital, Oriental Fortune Capital, YuanBio Venture Capital, Hongtai Capital Holdings, Shenzhen Credit Guarantee Group — 15 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 15 names
- ·Watchlist + deal alerts for Shenzhen Shanhai Innovation Technology
- ·The full record, as it builds
Funding rounds
No funding rounds for Shenzhen Shanhai Innovation Technology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Shenzhen Shanhai Innovation Technology
Developer of organic ionic liquids intended to provide new biological materials. The company's product offers advanced supramolecular modification technology, enhanced stability and transdermal absorption of active ingredients, and customized raw material development, enabling cosmetics manufacturers, health product developers, and biotechnological firms to improve product efficacy, reduce irritation, and accelerate innovation in the pan-health industry.
- Sector
- Healthcare
- HQ
- Shenzhen, China
- Founded
- 2017
- Employees
- 60
- Website
- shinehigh.cn/
- Ownership
- Privately Held (backing)
Shenzhen Shanhai Innovation Technology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Shenzhen Shanhai Innovation Technology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Shenzhen Shanhai Innovation Technology in its N-PORT filings yet. We sweep new filings monthly.